Integrated assessment of the serum magnesium-to-vitamin D3 ratio, micronutrient deficiencies, and inflammatory biomarkers in patients with migraine
Abstract
Migraine is a common neurovascular disease linked to complex metabolic or inflammatory changes that can lead to neuronal hyperexcitability and susceptibility to headache. In this study, associations between the serum magnesium-to-vitamin D 3 (Mg/VitD 3 ) ratio and other micronutrients and inflammatory biomarkers were evaluated and examined as a combined biochemical index in patients with migraine. A case - control study was carried out with 120 adult participants (60 migraine patients and 60 healthy controls of matched age and sex ) . The level of serum magnesium was determined by an automated colorimetric method, and 25-hydroxyvitamin D 3 was determined by enzyme-linked immunosorbent assay (ELISA). Serum calcium, vitamin B 12 , folic acid and C-reactive protein (CRP) were also measured. A Mg/VitD 3 ratio was determined for each individual. There were no significant differences between the two groups for any baseline demographic characteristics. Migraine patients exhibited significantly lower serum vitamin D 3 (18.1 ± 3.2 vs. 28.6 ± 4.3 ng/mL), magnesium (1.39 ± 0.22 vs. 2.00 ± 0.19 mg/dL), calcium (9.08 ± 0.51 vs. 9.32 ± 0.28 mg/dL), vitamin B12 (421.8 ± 193.6 vs. 489.4 ± 87.5 pg/mL), and folic acid (5.7 ± 1.3 vs. 12.4 ± 3.2 ng/mL), whereas CRP levels were markedly elevated (2.56 ± 1.31 vs. 0.48 ± 0.18 mg/L). The Mg/VitD 3 ratio was significantly reduced in migraine patients. All significant correlations were positive, with a strong positive correlation with magnesium (r = 0.843) and vitamin D 3 (r = 0.721); moderate positive correlations with folic acid, vitamin B 12 , and calcium; and a strong negative correlation with CRP (r = −0.589). Only magnesium, vitamin D 3 , folic acid, vitamin B 12 and CRP were independently associated with migraine (logistic regression analysis), while calcium was not. There is also concurrent micronutrient deficiency and syste m ic inflammation in migraine. The ratio of Mg/VitD 3 in serum is a promising integrated biomarker that includes metabolic and inflammatory disturbances and could have the potential to enhance biochemical evaluation and risk stratification in patients with migraine.References
Ashina, M., Katsarava, Z., Do, T. P., Buse, D. C., Pozo-Rosich, P., Özge, A., Krymchantowski, A. V., Lebedeva, E. R., Ravishankar, K., Yu, S., Sacco, S., Ashina, S., Younis, S., Steiner, T. J., & Lipton, R. B. (2021). Migraine: Epidemiology and systems of care. The Lancet, 397(10283), 1485–1495.
Bikle, D. D. (2022). Vitamin D regulation of immune function during Covid-19. Reviews in Endocrine and Metabolic Disorders, 23(2), 279–285.
Dai, Q., Zhu, X., Manson, J. E., Song, Y., Li, X., Franke, A. A., Costello, R. B., Rosanoff, A., Nian, H., Fan, L., Murff, H., Ness, R. M., Seidner, D. L., Yu, C., & Shrubsole, M. J. (2018). Magnesium status and supplementation influence vitamin D status and metabolism: Results from a randomized trial. The American Journal of Clinical Nutrition, 108(6), 1249–1258.
Domitrz, I., & Cegielska, J. (2022). Magnesium as an important factor in the pathogenesis and treatment of migraine – from theory to practice. Nutrients, 14(5), 1089.
Edvinsson, L., Haanes, K. A., Warfvinge, K., & Krause, D. N. (2018). CGRP as the target of new migraine therapies – successful translation from bench to clinic. Nature Reviews Neurology, 14(6), 338–350.
Noseda, R., & Burstein, R. (2013). Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain, 154(S1), S44–S53.
Paoletti, P., Bellone, C., & Zhou, Q. (2013). NMDA receptor subunit diversity: Impact on receptor properties, synaptic plasticity and disease. Nature Reviews Neuroscience, 14(6), 383–400.
Romani, A. M. (2011). Cellular magnesium homeostasis. Archives of Biochemistry and Biophysics, 512(1), 1–23.
Schwalfenberg, G. K., & Genuis, S. J. (2017). The importance of magnesium in clinical healthcare. Scientifica, 2017, 4179326.
Schytz, H. W., Birk, S., Wienecke, T., Kruuse, C., Olesen, J., & Ashina, M. (2008). PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain, 132(1), 16–25.
Steiner, T. J., Stovner, L. J., Jensen, R., Uluduz, D., & Katsarava, Z. (2020). Migraine remains second among the world’s causes of disability, and first among young women: Findings from GBD2019. The Journal of Headache and Pain, 21(1), 112–125.
Uwitonze, A. M., & Razzaque, M. S. (2018). Role of magnesium in vitamin D activation and function. The Journal of the American Osteopathic Association, 118(3), 181–189.
Workinger, J. L., Doyle, R. P., & Bortz, J. (2018). Challenges in the diagnosis of magnesium status. Nutrients, 10(9), 1202.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
